OUR JOURNEY

From strategy to

measurable action

The year connected long-term direction with practical resources, research and global engagement.

APR–JUN 2025

Evidence

shared globally

Patient-reported research was presented at AACR and EHA, while new collaborations strengthened the evidence base.

JUL–SEP 2025

Awareness

and advocacy

The Honest Talk campaign reached millions, while policy resources expanded.

OCT–DEC 2025

Community

convened

Global Summit 2025 in Amsterdam helped Members turn lived experience and data into advocacy action.

JAN–MAR 2026

Participation

at scale

The tenth Global Patient Survey closed with 9,991 responses in 21 languages.

ABOUT LYMPHOMA COALITION

Lymphoma Coalition is the leading global coalition of patient organisations dedicated to supporting people affected by lymphoma and chronic lymphocytic leukaemia (CLL).

Through research, education, advocacy and collaboration, the Coalition helps ensure that patient experiences remain central to healthcare decision-making.

A trusted global voice for people affected by lymphoma and CLL

Vision

A better future for everyone impacted by lymphoma.

Mission

To generate and provide trusted information, knowledge and best practices that influence and make equitable care possible.

STRATEGIC DIRECTION

Building the future

of lymphoma care

Strategy 2025–2030 provides a clear pathway for applying what Lymphoma Coalition learns from patient experiences to achieve meaningful, measurable and actionable impact.

Influence policy to improve optimal care

Support policy initiatives that improve access, quality of care and health equity.

Deliver usable evidence and information

Translate research and education into practical action.

Empower patient leaders and organisations

Build capacity and amplify patient voices.

Connect diverse stakeholders

Bring together patients, clinicians, researchers, industry and policymakers.

Ensure impact at every level

Make global evidence useful in regional and local contexts.

Explore Strategy 2025–2030 →

CONNECTING THE GLOBAL COMMUNITY

Learning together.

Acting together.

Global programmes created space for patient leaders to

exchange knowledge, strengthen advocacy and reach people

in the languages and communities that matter to them.

Global Summit 2025

In Amsterdam, Members and partners explored how lived experience, credible evidence and collaboration can strengthen patient advocacy.

Explore the Global Summit →

Karen Van Rassel

Leadership Award

APCL was recognised for patient-centred support, national advocacy and sustainable programmes improving lymphoma care in Portugal.

Read the award story →

World Lymphoma Awareness Day

Honest Talk reached 10,238,197 people, with Member voices featured in eight languages and five local scholarships supporting action across three continents.

Watch the campaign video →

Local scholarship recipients:

ADVANCING PATIENT-CENTRED CARE

Shared frameworks.

Stronger evidence.

Two major initiatives helped connect patient priorities with practical action in care, advocacy, research and policy.

Lymphoma Patient Charter

Explore the Charter →

A global framework supporting timely diagnosis, equitable access, supportive care and meaningful involvement in healthcare decisions.

Timely diagnosis

Shared decision-making

Reliable information

Psychosocial support

Survivorship care

Patient involvement

Discover the GPS →

Global Patient Survey 2026

The tenth survey transformed lived experience into actionable evidence across diverse healthcare systems.

9,991

responses

21

languages

24

country reports

GENERATING EVIDENCE AND DRIVING CHANGE

Patient experience at the centre of research

FY2026 research explored treatment experience, quality of life, psychosocial wellbeing, shared decision-making, diagnostic pathways and access to care.

POLICY & ADVOCACY RESOURCES

Practical tools for stronger, evidence-informed advocacy

COMMUNITY ADVISORY BOARDS (CABs)

Four international CABs

Structured opportunities with Incyte, Novartis, Roche and Takeda brought lived experience into research, education and programme development.

Follicular lymphoma

Shared decision-making

Hodgkin lymphoma

Quality of life

Large B-cell lymphoma

Supportive care

DLBCL

Access and HTA

STRENGTHENING PARTNERSHIPS AND COLLABORATION

Connecting patient insight with global expertise

Strategic alliances helped bring patient priorities

into clinical research, education, regulation, policy

and healthcare decision-making.

ESMO

Exploring the Association of Side Effects with Depression in Patients with Chronic Lymphocytic Leukaemia Who Have Received Treatment

ISPOR 2026

Patient-Reported Experiences with Cancer-Related Fatigue Following CAR T-Cell Therapy

EHA 2026

Incidence and Impact of Misdiagnosis in Diffuse Large B-Cell Lymphoma (DLBCL)

LOOKING AHEAD TO FY2027

Building on momentum

In FY2027, Lymphoma Coalition will continue advancing Strategy 2025–2030 and supporting people affected by lymphoma and CLL through evidence, advocacy, education and collaboration.

1

Publish GPS 2026 findings

Turn participation into evidence Members can use.

2

Implement the Patient Charter

Support practical conversations about access, quality and equity.

3

Expand policy and advocacy

Strengthen resources and capacity across the network.

4

Prepare WLAD and Global Summit 2026

Create new opportunities to connect, learn and act.

LEADERSHIP MESSAGE

A message from

Susan Thornton

“Our progress is a direct result of the resilience, collaboration and unwavering compassion of our Members and partners.”

Watch Susan Thornton, Board Chair, reflect on the year and the shared commitment behind Lymphoma Coalition’s global impact.

Susan Thornton · Board Chair · Lymphoma Coalition

Lymphoma Coalition extends its sincere gratitude to Member organisations, research partners, sponsors, patients and care partners.

​

This support and collaboration make progress possible for the global lymphoma and CLL community.

MEMBER ORGANISATIONS · RESEARCH PARTNERS · SPONSORS · PATIENTS · CARE PARTNERS

Thank you for making this impact possible

ACKNOWLEDGEMENTS

EXPLORE THE COMPLETE STORY

See every project, partnership and insight in the FY2026 Impact Report.

Download the full report for detailed results, research highlights and links to all featured resources.

A better future for everyone impacted by lymphoma.

FOLLOW

Instagram · Facebook · YouTube · LinkedIn · X

Not-For-Profit Business Number: 803211465 · © Lymphoma Coalition